Divya Saira Lal

Divya Lal practices at Northwestern Medicine McHenry Hospital in Mchenry, Illinois, part of Northwestern Memorial HealthCare.

Divya Lal's NPI, 1902307390, was assigned on February 22, 2018. Divya Lal holds Illinois license 036157344.

Divya Lal's primary practice is Northwestern Medicine McHenry Hospital, at 4201 Medical Center Drive, Mchenry, IL 60050 in Mc Henry County. The practice phone is (815) 344-5000.

Divya Lal's primary practice is Northwestern Medicine McHenry Hospital in Mchenry, Illinois, part of Northwestern Memorial HealthCare. Divya Lal is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Divya Lal to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Divya Lal practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Divya Lal's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Divya Lal's licenses on file in 2 states: Illinois and Pennsylvania.

CMS data shows 1,012 Medicare services from Divya Lal across 5 procedure codes in 2024, for 367 Medicare patients. Medicare paid $86,311 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 367 Medicare patients who saw Divya Lal in 2024. The largest group is 75 to 84, with 144 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Divya Lal's median patient age at 77, with 52% women.

In 2024, Divya Lal wrote 348 Medicare Part D claims for 161 patients. 89% of them were for generic drugs. CMS names the drug for 141 of them, across 9 drugs with 11 or more claims each, at $749 in total drug cost. In 2023, CMS named 114 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Divya Lal for performance year 2024, reported through an alternative payment model (APM). Divya Lal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Divya Lal, published from 2021 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Advertising. Divya Lal has published most often in Am J Emerg Med. Divya Lal's most frequent co-authors are Rebecca K. Jeanmonod, MD, Kim L. Kwai, MD and Marian P. McDonald, MD.

CMS Open Payments shows 7 general payments to Divya Lal from 2 drug and device companies from 2018 to 2020. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $157.